newsfilter
← Latest News
GlobeNewswire·

23andMe to Report Q1 FY2025 Financial Results

ME

SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (NASDAQ:ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and